A novel long-acting formulation of oral buprenorphine/naloxone produces prolonged decreases in fentanyl self-administration by rhesus monkeys

Foltin, R. W., Zale, S., Sykes, K. A., Nagaraj, N., Scranton, R. E., & Comer, S. D. (2022). A novel long-acting formulation of oral buprenorphine/naloxone produces prolonged decreases in fentanyl self-administration by rhesus monkeys. Drug and Alcohol Dependence, 239, 109599. https://doi.org/10.1016/j.drugalcdep.2022.109599
Authors:
Richard W. Foltin
Stephen Zale
Kristine A. Sykes
Nayana Nagaraj
Richard E. Scranton
Sandra D. Comer
Affiliated Authors:
Richard W. Foltin
Sandra D. Comer
Columbia Affiliation:
Subjects:
Buprenorphine (MeSH)
Opioid-Related Disorders (MeSH)
Author Keywords:
opioid use disorder
buprenorphine
fentanyl
self -administration
medication development
non -human primate
non-human primate
self-administration
elink
Publication Type:
Article
Unique ID:
10.1016/j.drugalcdep.2022.109599
PMID:
35963210
DOI:
10.1016/j.drugalcdep.2022.109599
Journal:
Drug and Alcohol Dependence
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View PubMed Record
View Web of Science Record

Record Created: